中医药是如何跨越海峡，在台湾落地生根的？展馆内的文字介绍说，浙江文人沈光文于1652年因台风漂 流至台湾并定居30余年，后在台南一带设帐教学、行医救人，是第一位在台湾留下记录的中医师。 此后，随着闽粤两地的汉人移入台湾，不少掌握中医药技艺的大陆移民也随之而来，让中医药逐渐在台 湾社会扎根、传播，一步步融入台湾百姓日常。时至今日，走在台湾各县市街头，中医诊所林立，稍有 名气的中医门诊常常一号难求。数据显示，台湾目前有中医诊所4000多家，中医师约8000位。 新华社台北12月8日电（记者王承昊、黄硕）记者日前探访了坐落于台中的台湾"中国医药大学"立夫中 医药博物馆，作为台湾唯一一家以中医药为主题的专业博物馆，这里虽然没有热闹的打卡人流，却有泛 黄的古籍和静静陈列的药材。一器一物间，悄然诉说着中医药的千年智慧和在两岸的传承印记。 博物馆自1987年筹建，1991年正式开馆，共分为5个展室，内容包括中医药历史文物、药用植物动物矿 物标本、台湾药用植物分布、人参展示区等，收藏丰富的中医药文物，不乏稀有典藏品。其中，部分展 品为大陆友好机构提供。 一步入展馆，记者目光便被墙面上数幅扁鹊、张仲景、李时珍等中国古代名医的肖 ...

Group 1 - The core viewpoint of the article highlights the increasing demand for traditional Chinese medicine (TCM) therapy and services in China, driven by an aging population and rising health concerns among younger demographics [1][6] - The TCM therapy market in China reached a scale of 700 billion yuan in 2023, with projections to exceed 1.3 trillion yuan by 2028, indicating a robust growth trajectory [1][6] - Charming Medical Limited, a Hong Kong-based TCM therapy company, has filed for an IPO in the U.S. with plans to raise between 6.4 million to 9.6 million USD by offering 160,000 shares at a price range of 4 to 6 USD per share [1][12] Group 2 - Charming Medical Limited operates four health centers in Hong Kong under the "Beauty Lab" brand, offering a range of TCM-based beauty, health, and postpartum services [2][5] - The company's revenue for the fiscal year 2023 to 2024 is projected to grow by 24.1%, with revenues of 2.6415 million USD and 2.9585 million USD for the respective years [2][4] - Despite revenue growth, the company has not increased its customer base, remaining at 1,941 clients, which raises concerns about future growth potential [5] Group 3 - The TCM beauty market is expected to thrive, with a significant increase in consumer interest and government support for TCM practices, as outlined in the "Healthy China 2030" plan [6][7] - The TCM women's health market has shown a compound annual growth rate (CAGR) of 7.9% from 2019 to 2023, with expectations to reach 4.666 billion HKD by 2030 [8] - The company plans to use the funds raised from the IPO for market expansion in Southeast Asia and the Greater Bay Area, technology development for health monitoring devices, and brand enhancement through international media [12]